Department for Hemapheresis with Tissue Bank,
Blood Transfusion Institute of the Federation of Bosnia and Herzegovina
, Sarajevo
, Bosnia and Herzegovina
Department for Hemapheresis with Tissue Bank,
Blood Transfusion Institute of the Federation of Bosnia and Herzegovina
, Sarajevo
, Bosnia and Herzegovina
Department for Hemapheresis with Tissue Bank,
Blood Transfusion Institute of the Federation of Bosnia and Herzegovina
, Sarajevo
, Bosnia and Herzegovina
Aim To analyse changes in haematological values after plateletpheresis in donor population with regard to donor safety. Methods A retrospective study was conducted on first time and repeated healthy donors over a period of eight months in the Blood Transfusion Institute in the Federation of Bosnia and Herzegovina in Sarajevo. A total of 75 plateletpheresis procedures performed using Amicus continuous flow cell separator were evaluated. Various pre- and post-donation haematological values were measured in all donors: haemoglobin concentration (Hb), haematocrit (Hct), red blood cell count (RBC), platelet count (PLT), white blood cell count (WBC), mean platelet volume (MPV), mean corpuscular volume (MCV), mean corpuscular haemoglobin (MCH), and mean corpuscular haemoglobin concentration (MCHC). Results A significant decrease in post-donation Hb, Hct, RBC, PLT, MCHC (p<0.000) and WBC (p=0.003), and a significant increase in MPV (p=0.011) and MCV (p<0.000) was found. Percentage reduction of haematological parameters Hb, Hct, RBC, PLT, WBC and MCHC decrease of 6.6%, 6.5%, 5.9%, 24%, 4.6% and 0.3%, respectively, in their respective count was noted postdonation. Eight (11%) donors had a post-procedure platelet count less than 150x10e9/L. Twenty two donors (29%) experienced mild side effects due to hypocalcaemia. Conclusion Plateletpheresis procedures are generally safe and well tolerated, without evident associated clinical manifestations on healthy donors.
Suresh B, Arun R, Yashovardhan A, Deepthi K, Sreedhar Babu KV, Jothibai DS. Changes in preand post-donation haematological parameters in plateletpheresis donors. J Clin Sci Res. 2014;3:85–9.
2.
Mahmood W, Rifin N, Iberahim S, Long Tuan M, Mustafa R. Significant reduction in hematological values after plateletpheresis: clinical implication to the donor. Asian Biomed. 2011;5:393–5.
3.
Das SS, Chaudhary R, Verma SK, Ojha S, Khetan D. Pre- and post donation haematological values in healthy donors undergoing plateletpheresis with five different systems. Blood Transfus. 2009;7:188–92.
4.
Sachdeva P, Kaur G, Basu S, Tahlan A. Assessment of factors affecting the platelet yield using continuous flow cell separator. Int J Biomed Res. 2014;5:196–9.
5.
Chaudhary R, Das SS, Khetan D, Ojha S, Verma S. Donor safety issues in high-dose platelet collection using the latest apheresis systems. Transfus Altern Transfus Med. 2010;11:1–7.
6.
Khajuria K, Sawhney V, Sharma R, Gupta S. Adverse donor reaction during and after plateletpheresis in a tertiary care centre. Int J Res Med Sci. 2017;5:1221–3.
7.
AK SN, M NA, AT NS, M N, E A, A NA, et al. Effects of plateletpheresis on blood coagulation parameters in healthy donors at National Blood Centre, Kuala Lumpur, Malaysia. Transfus Apher Sci. 2013;49:507–10.
8.
Farahat MH, Sharaf MA. Hematological and biochemical parameter alteration after plateletpheresis donation. Egypt J Haematol. 2016;41:174–9.
9.
Gite V, Dhakane M. Analysis of pre- and post-donation haematological values in plateletpheresis donors. Apollo Medicine. 2015;12:123–5.
10.
Nikhil DS, Snigdha. Haematological changes in donors post apheresis. J Clin Diagn Res. 2021;15:39–41.
11.
Beyan C, Cetin T, Kaptan K, Nevruz O. Effect of plateletpheresis on complete blood count values using different cell separator systems in healthy donors. Transfus Apher Sci. 2003;29:45–7.
12.
Lewis SM, Anderson NA, Pamphilon DH. Comparability of haematological and biochemical parameters before and after apheresis of volunteer donors. Vox Sang. 1991;61(78).
13.
Aslam MU, Alam M, Zafar MU, Akhter M, Awais H, Mannan T, et al. Preliminary study of variation in pre and post hematological values of healthy plateletpheresis donors. Int J Endorsing Health Sci Res. 2021;9:360–4.
14.
Lowe E, Pendry K, Hunt L. Analysis of pre- and post-donation haematological values in plateletpheresis donors. Vox Sang. 1993;65:209–11.
15.
Lazarus EF, Browning J, Norman J, Oblitas J, Leitman SF. Sustained decreases in platelet count associated with multiple, regular plateletpheresis donations. Transfusion. 2001;41:756–61.
16.
Setiadarma D, Angela. Effects of plateletpheresis on hematological parameters. World J Curr Med Pharm Res. 2022;4:122–6.
17.
Nomani L, Raina TR, Sidhu M. Feasibility of applying the 2day deferral for repeat plateletpheresis: Indian perspective. Transfus Apher Sci. 2013;48:341–3.
18.
Beutler E, Waalen J. The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration? Blood. 2006;107:1747–50.
19.
Chaundhary R, Das SS, Khetan D, Sinha P. Effect of donor variables on yield in single donor plateletpheresis by continuous flow cell separator. Transfus Apher Sci. 2006;34:157–61.
20.
Lee G, Arepally GM. Anticoagulation techniques in apheresis: from heparin to citrate and beyond. J Clin Apher. 2012;27:117–25.
21.
Dogra K, Fulzele P, Rout D, Chaurasia R, Coshic P, Chatterjee K. Adverse events during apheresis procedures: audit at a tertiary hospital. Indian J Hematol Blood Transfus. 2017;33:106–8.
22.
Blood Transfusion EC. Guide to the Preparation, Use and Quality Assurance of Blood Components; Recommendation No.R(95)15; 21st Edition. European Directorate for the Quality of Medicines & Health Care Council of Europe. 2023;254–6.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
,
